EXIGENCE ONE PATCH- exigence one patch patch 
DirectRx

----------

EXIGENCE ONE PATCH

Topical Analgesic

For external use only not intended for ingestion.

Do not use in large quantities, particularly over raw surfaces, or blistered areas.

Avoid contact with the eyes.

Stop use and ask doctor if condition worsens, or if symtoms persist for more than 7 days or clear up and occur again within a few days.

If swallowed, get medical help, or contact a Poison Control Central right away.

Ask a health professional before use.

Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times a daily.
Children under 2 years of age: consult a doctor.

Store at 20-25 oC (68-77 oF) and protect from moisture.

polyacrylamide, vinol, sodium polyacrylate; acrylate polymerization, purified water.

Questions?

(310) 320-0100

Lidocaine 4%

Menthol 1%

hi

EXIGENCE ONE PATCH 
exigence one patch patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72189-296(NDC:81902-102)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL, UNSPECIFIED FORM - UNII:L7T10EIP3A) MENTHOL, UNSPECIFIED FORM1 g  in 100 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
POLYACRYLAMIDE (10000 MW) (UNII: E2KR9C9V2I)  
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
ETHENYL (UNII: PQ2K3G3591)  
ACRYLATES CROSSPOLYMER-6 (UNII: 4GXD0Q3OS3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72189-296-014 g in 1 PATCH; Type 0: Not a Combination Product12/02/202112/02/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01712/02/202112/02/2022
Labeler - DirectRx (079254320)
Registrant - DirectRx (079254320)
Establishment
NameAddressID/FEIBusiness Operations
DirectRx079254320repack(72189-296)

Revised: 10/2023
 
DirectRx